| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human chemokine (C-X-C motif) ligand 12 (CXCL12), transcript variant 2. from ORIGENE TECHNOLOGIES | TP723405 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-X-C motif) ligand 16 (CXCL16), transcript variant 1. from ORIGENE TECHNOLOGIES | TP723062 | 25 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-X-C motif) ligand 16 (CXCL16), transcript variant 2 from ORIGENE TECHNOLOGIES | TP723866 | 10 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 8 (DPP8), transcript variant 3 from ORIGENE TECHNOLOGIES | LY430697 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 8 (DPP8), transcript variant 4 from ORIGENE TECHNOLOGIES | LY403668 | 100 ug | ORIGENE TECHNOLOGIES |
| Diphosphoinositol pentakisphosphate kinase 1 (PPIP5K1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY415117 | 100 ug | ORIGENE TECHNOLOGIES |
| DIRAS family, GTP-binding RAS-like 1 (DIRAS1) from ORIGENE TECHNOLOGIES | LY408035 | 100 ug | ORIGENE TECHNOLOGIES |
| DIRAS family, GTP-binding RAS-like 2 (DIRAS2) from ORIGENE TECHNOLOGIES | LY413684 | 100 ug | ORIGENE TECHNOLOGIES |
| DIRAS family, GTP-binding RAS-like 3 (DIRAS3) from ORIGENE TECHNOLOGIES | LY401484 | 100 ug | ORIGENE TECHNOLOGIES |
| DIRAS2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400740 | 1 kit | ORIGENE TECHNOLOGIES |
| DIRAS3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402787 | 1 kit | ORIGENE TECHNOLOGIES |
| DIRAS1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406160 | 1 kit | ORIGENE TECHNOLOGIES |
| Diras1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504588 | 1 kit | ORIGENE TECHNOLOGIES |
| Diras2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504589 | 1 kit | ORIGENE TECHNOLOGIES |
| DIRAS1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH306160 | 10 ug | ORIGENE TECHNOLOGIES |
| DIRAS2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300740 | 10 ug | ORIGENE TECHNOLOGIES |
| DIRAS3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302787 | 10 ug | ORIGENE TECHNOLOGIES |
| DIRC2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408024 | 1 kit | ORIGENE TECHNOLOGIES |
| DIRC1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415765 | 1 kit | ORIGENE TECHNOLOGIES |
| Dirc2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504590 | 1 kit | ORIGENE TECHNOLOGIES |
| D730048I06Rik - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504245 | 1 kit | ORIGENE TECHNOLOGIES |
| Disabled homolog 1 (Drosophila) (DAB1) from ORIGENE TECHNOLOGIES | LY402829 | 100 ug | ORIGENE TECHNOLOGIES |
| Disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) (DAB2) from ORIGENE TECHNOLOGIES | LY400534 | 100 ug | ORIGENE TECHNOLOGIES |
| DISC1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN411632 | 1 kit | ORIGENE TECHNOLOGIES |
| Disc1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504594 | 1 kit | ORIGENE TECHNOLOGIES |
| DISC1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH312015 | 10 ug | ORIGENE TECHNOLOGIES |
| Discoidin, CUB and LCCL domain containing 2 (DCBLD2) from ORIGENE TECHNOLOGIES | LY403322 | 100 ug | ORIGENE TECHNOLOGIES |
| Discoidin domain receptor tyrosine kinase 1 (DDR1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415575 | 100 ug | ORIGENE TECHNOLOGIES |
| Leprel2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN509232 | 1 kit | ORIGENE TECHNOLOGIES |
| Leprel4 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN509233 | 1 kit | ORIGENE TECHNOLOGIES |
| LEPRE1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH322535 | 10 ug | ORIGENE TECHNOLOGIES |
| LEPR - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN218456 | 1 kit | ORIGENE TECHNOLOGIES |
| LEPR - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN218456BN | 1 kit | ORIGENE TECHNOLOGIES |
| LEPR - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN218456LP | 1 kit | ORIGENE TECHNOLOGIES |
| LEPR - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN218456RB | 1 kit | ORIGENE TECHNOLOGIES |
| LEPR - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418456 | 1 kit | ORIGENE TECHNOLOGIES |
| Lepr - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN509229 | 1 kit | ORIGENE TECHNOLOGIES |
| LEPROT - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408878 | 1 kit | ORIGENE TECHNOLOGIES |
| Leprot - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN509234 | 1 kit | ORIGENE TECHNOLOGIES |
| LEPROTL1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400535 | 1 kit | ORIGENE TECHNOLOGIES |
| Leprotl1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN509235 | 1 kit | ORIGENE TECHNOLOGIES |
| LEPROTL1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300535 | 10 ug | ORIGENE TECHNOLOGIES |
| Leptin (LEP) from ORIGENE TECHNOLOGIES | LY400087 | 100 ug | ORIGENE TECHNOLOGIES |
| Leptin receptor (LEPR), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400832 | 100 ug | ORIGENE TECHNOLOGIES |
| Leptin receptor (LEPR), transcript variant 2 from ORIGENE TECHNOLOGIES | LY424100 | 100 ug | ORIGENE TECHNOLOGIES |
| Leptin receptor overlapping transcript (LEPROT) from ORIGENE TECHNOLOGIES | LY413721 | 100 ug | ORIGENE TECHNOLOGIES |
| Leptin receptor overlapping transcript-like 1 (LEPROTL1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402424 | 100 ug | ORIGENE TECHNOLOGIES |
| Leptin Sandwich ELISA Kit from ORIGENE TECHNOLOGIES | EA101039 | 96-well strip plate | ORIGENE TECHNOLOGIES |
| Lethal giant larvae homolog 1 (Drosophila) (LLGL1) from ORIGENE TECHNOLOGIES | LY418186 | 100 ug | ORIGENE TECHNOLOGIES |
| Lethal giant larvae homolog 2 (Drosophila) (LLGL2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423111 | 100 ug | ORIGENE TECHNOLOGIES |